SAN DIEGO--(BUSINESS WIRE)--Sept. 1, 2006--Inovio Biomedical Corporation (AMEX:INO), a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that the Company's president and CEO, Avtar Dhillon, MD, will present a corporate overview on the company at the Thomas Weisel Partners Healthcare Conference in Boston, MA, on Wednesday, September 6, 2006 at 3:15 p.m. EDT.
